Influenza vaccines with reduced amounts of squalene

Details for Australian Patent Application No. 2010212550 (hide)

Owner Novartis AG

Inventors Contorni, Mario; O'Hagan, Derek; Groth, Nicola

Agent FB Rice

Pub. Number AU-A-2010212550

PCT Pub. Number WO2010/092479

Priority 61/207,385 10.02.09 US

Filing date 10 February 2010

Wipo publication date 19 August 2010

International Classifications

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

18 August 2011 PCT application entered the National Phase

  PCT publication WO2010/092479 Priority application(s): WO2010/092479

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212553-Migration and plasma enhanced chemical vapor deposition

2010212548-Influenza vaccines with increased amounts of H3 antigen